Home Seekyo

Seekyo

In operation
Seed Round Financing
Intelligent Drug Development for Cancer Treatment
Basic
Enterprise Profile

Basic Information

SEEKYO is a private biotechnology company dedicated to developing next-generation chemotherapies that provide effective treatment options for cancer patients without adverse effects. SEEKYO is designing intelligent drugs capable of selectively targeting the microenvironment of solid tumors while preserving healthy tissue.
SEEKYO Therapeutics
France
less than 15 people
January 01, 2018
contact@seekyo-therapeutics.com

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Biotechnology
Concept
Tumor Therapeutic Products
Application Scenarios
Innovative Drugs